Bendamustine in the treatment of chronic lymphocytic leukemia: Results and future perspectives

被引：36

作者：

Aivado, M

Schulte, K

Henze, L

Burger, J

Finke, J

Haas, R

机构：

[1] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany

[2] Univ Freiburg, Dept Hematol & Oncol, Freiburg, Germany

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 04期

关键词：

D O I：

10.1053/sonc.2002.34875

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：19 / 22

页数：4

共 18 条

[1]

AIVADO M, 2001, P AN M AM SOC CLIN, V20, pA306

[2]

ANGER G, 1975, Deutsche Gesundheitswesen, V30, P1280

[3]

BREMER K, 1999, ANN ONCOL, V10, P127

[4] National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].

Cheson, BD ;

Bennett, JM ;

Grever, M ;

Kay, N ;

Keating, MJ ;

OBrien, S ;

Rai, KR .

BLOOD, 1996, 87 (12) :4990-4997

[5] Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma [J].

Churn, M ;

Clough, V .

CLINICAL ONCOLOGY, 2001, 13 (04) :273-275

[6] Rituximab therapy of patients with B-cell chronic lymphocytic leukemia [J].

Huhn, D ;

von Schilling, C ;

Wilhelm, M ;

Ho, AD ;

Hallek, M ;

Kuse, R ;

Knauf, W ;

Riedel, U ;

Hinke, A ;

Srock, S ;

Serke, S ;

Peschel, C ;

Emmerich, B .

BLOOD, 2001, 98 (05) :1326-1331

[7]

Kalil N, 1999, Oncologist, V4, P352

[8] Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia [J].

Kath, R ;

Blumenstengel, K ;

Fricke, HJ ;

Höffken, K .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (01) :48-54

[9]

Kath R., 2000, Onkologie, V23, P171

[10] Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia [J].

O'Brien, SM ;

Kantarjian, AM ;

Cortes, J ;

Beran, M ;

Koller, CA ;

Giles, FJ ;

Lerner, S ;

Keating, M .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1414-1420

← 1 2 →